Dapsone for Pneumocystis jirovecii pneumonia prophylaxis - applying theory to clinical practice with a focus on drug interactions.

Drug Metabolism and Personalized Therapy
Carmela Emma CoralloSharon Avery

Abstract

Pneumocystis jirovecii pneumonia (PJP) is a potentially life-threatening infection that occurs in immunocompromised individuals. The incidence can be as high as 80% in some groups but can be reduced to less than 1% with appropriate prophylaxis. HIV-infected patients with a low CD4 count are at the highest risk of PJP. Others at substantial risk include haematopoietic stem cell and solid organ transplant recipients, those with cancer (particularly haematologic malignancies), and those receiving glucocorticoids, chemotherapeutic agents, and other immunosuppressive medications. Trimethoprim-sulfamethoxazole is an established first-line line agent for prevention and treatment of PJP. However, in some situations, this medication cannot be used and dapsone is considered a suitable cost-effective second line agent. However, information on potential interactions with drugs commonly used in immunosuppressed patients is lacking or contradictory. In this this article we review the metabolic pathway of dapsone with a focus on interactions and clinical significance particularly in patients with haematological malignancies. An understanding of this process should optimise the use of this agent.

References

Apr 1, 1992·Archives of Internal Medicine·S M BorcherdingT H Self
Jul 24, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·W T Hughes
Mar 9, 2000·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·M J VasconcellesJ H Antin
Apr 5, 2002·Biopharmaceutics & Drug Disposition·Byoung C KangWan G Shin
Jan 25, 2005·Drug Metabolism and Drug Interactions·Ken-ichi Fujita
Jun 29, 2005·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Dario SangioloMichael Boeckh
Oct 31, 2008·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Priyumvada M NaikAndres Pelaez
Sep 15, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Marcie TomblynUNKNOWN Centers for Disease Control and Prevention
May 15, 2010·Infectious Disease Clinics of North America·Anna K PersonBarbara D Alexander
Jan 14, 2011·Anaesthesia and Intensive Care·A SubramaniamR Nagappan
Jan 20, 2011·Cancer·Adam J EsbenshadeDebra L Friedman
Mar 23, 2011·Journal of Clinical Pharmacology·Mahmoud AbourayaLauren A Trepanier
Nov 19, 2011·Transplant Infectious Disease : an Official Journal of the Transplantation Society·N Goto, S Oka
Aug 10, 2013·Journal of Thrombosis and Haemostasis : JTH·C Rodrigo, L Gooneratne
Jan 24, 2014·Expert Opinion on Drug Metabolism & Toxicology·Petra MatoulkováJiří Vlček
Jan 28, 2014·PloS One·Taysa Ribeiro SchalcherMarta Chagas Monteiro
Mar 1, 2014·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Jennifer A LewisGlenn J Lesser
Sep 16, 2015·Transplant Infectious Disease : an Official Journal of the Transplantation Society·R A EvansA M Fugit
May 22, 2016·Journal of Clinical Pharmacy and Therapeutics·K L WallaceJ C Williamson
Jul 25, 2017·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Carmela CoralloOrla Morrissey
Nov 25, 2018·Journal of Fungi·P Lewis WhiteMatthijs Backx
Feb 6, 2019·Journal of Infection Prevention·Andrea DentonJude Robinson

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

HIV/AIDS-Related Malignancies

HIV/AIDS infection increases the risk of non-communicable diseases common in the aged including HIV/AIDS-related malignancies. Discover the latest research in HIV/AIDS-related malignancies.